phase 3 clinical trial


Also found in: Dictionary, Thesaurus, Encyclopedia.

phase 3 clinical trial

Phase 3 study. See Phase study.
References in periodicals archive ?
In both of the Phase 3 clinical trials, there were no differences in the overall incidence of side effects between the placebo and drug treated groups.
Cerus and Baxter are submitting the results of the European Phase 3 clinical trial for presentation at the annual meeting of the American Society of Hematology in December 2000.
The product has been Fast Tracked by the FDA and the Company has commenced a Phase 3 clinical trial.
The primary objective of the Phase 3 clinical trials with Arasine in patients undergoing coronary artery bypass surgery is to demonstrate that Arasine reduces the incidence of acute myocardial infarction and other adverse cardiovascular outcomes associated with the surgery.
This Phase 3 clinical trial was a randomized, double-blind, placebo-controlled, multi-center, parallel group trial designed to assess the efficacy and safety of 1mg and 3mg of SILENOR[TM] in elderly patients with chronic primary insomnia.
Gensia plans to complete its Phase 3 clinical trials with Arasine in coronary artery bypass surgery in April 1992 with enrollment of approximately 1,200 patients.
CancerVax has been evaluating Canvaxin(TM) in a Phase 3 clinical trial for the treatment of patients with Stage III melanoma in collaboration with Serono.
The phase 3 clinical trial was a double-blind, randomized, placebo-controlled study that enrolled AMI patients with opioid-induced constipation.
CancerVax anticipates that enrollment in the Phase 3 clinical trial of Canvaxin(TM) for patients with Stage III melanoma will be completed in 2004.
The experimental product is currently in a phase 3 clinical trial for the potential treatment of CFS and in two Phase 2b clinical trials for other chronic debilitating diseases.
CancerVax Corporation (NASDAQ:CNVX) announced today that it has completed the planned enrollment of 1,118 patients into its Phase 3 clinical trial of Canvaxin(TM) for the treatment of patients with Stage III melanoma.
and Roche Holdings AG, announced positive results from a randomized, Phase 3 clinical trial in late-stage NSCLC for their EGFR tyrosine kinase inhibitor, Tarceva(TM) (erlotinib HCl).